Jiye Liu

Prof. Dr. Jiye Liu

Shandong Cancer Hospital and Institute, Jinan, Shandong, China
orcid

Biography

my primary research focused on drug resistance of hematologic malignancies, particularly in multiple myeloma (MM), studying the mechanisms of resistance to immune-targeted therapies and identifying novel targets for anti-tumor drugs. I mainly utilized the CRISPR-Cas9 screen system, combined with mouse model in vivo to explore the genes related to the regulation of tumor cell resistance to different anti-tumor drugs under different treatment conditions, and to clarify the molecular mechanism, providing a preclinical theoretical basis for the establishment of strategies to reverse tumor drug resistance and effectively promotes the clinical transformation of related programs in the treatment of MM. Additionally, based on newly discovered anti-tumor targets, designing new drugs to treat cancer.

Affiliations

Shandong Cancer Hospital and Institute

Jinan, Shandong, China

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.